Holen Sie sich die Stockscreener-App
24.58
3.61%
-0.92
Handel nachbörslich:
25.81
1.23
+5.00%
Schlusskurs vom Vortag:
$25.50
Offen:
$25.05
24-Stunden-Volumen:
5.09M
Relative Volume:
0.99
Marktkapitalisierung:
$12.22B
Einnahmen:
$4.72B
Nettoeinkommen (Verlust:
$-232.00M
KGV:
-52.71
EPS:
-0.4663
Netto-Cashflow:
$284.00M
1W Leistung:
-2.15%
1M Leistung:
-6.15%
6M Leistung:
+25.34%
1J Leistung:
+132.99%
1-Tages-Spanne:
$24.57
$25.50
1-Wochen-Bereich:
$23.76
$25.68
52-Wochen-Spanne:
$8.02
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
24.58 | 12.68B | 4.72B | -232.00M | 284.00M | -0.4663 |
TAK
Takeda Pharmaceutical Co Adr
|
18.06 | 57.78B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
116.63 | 49.27B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.75 | 43.48B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.78 | 34.31B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
532.53 | 23.74B | 3.18B | 1.33B | 1.04B | 27.90 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Hochstufung | Argus | Hold → Buy |
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Elanco Gets Investors’ Dog Itch Drug Development Suit Dismissed - Bloomberg Law News
Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost - MSN
Syngulon announces licensing agreement with Elanco Animal Health - PRWeb
Elanco (ELAN) CEO receives deferred stock units in compensation grant - Stock Titan
Elanco (NYSE: ELAN) executive receives new deferred stock unit grant - Stock Titan
Elanco (ELAN) CFO receives 8.216 deferred stock units as compensation award - Stock Titan
Elanco Animal (ELAN) climbs 7.6% on upbeat outlook, sets sights on AI - MSN
ELAN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Pricier vet care: Fewer visits but still many $11,000 surgeries - Fortune
New Mexico Educational Retirement Board Invests $2 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Shares Down 3.01% on Mar 20 - GuruFocus
ELAN Stock Price, Quote & Chart | ELANCO ANIMAL HEALTH INC (NYSE:ELAN) - ChartMill
Where is Elanco Animal Health Incorporated (ELAN) headed according to the Street? - MSN
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board - The Manila Times
Former Elanco director joins ImmuCell board in calf-health push - Stock Titan
Animal Health Market size to reach $199.1 Billion by 2035 | Key - openPR.com
Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains? - Yahoo Finance
Elanco Animal (ELAN) Climbs 7.6% on Upbeat Outlook, Sets Sights on AI - Insider Monkey
Chipmakers Recap: What is the next catalyst for Elanco Animal Health IncorporatedRecession Risk & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Elanco jumps as investors focus on upbeat 2026 outlook after strong Q4 results - Quiver Quantitative
Elanco Animal Health (NYSE:ELAN) Shares Up 7.1%Here's What Happened - MarketBeat
Elanco Animal Health Incorporated $ELAN Holdings Cut by Holocene Advisors LP - MarketBeat
CSM Advisors LLC Takes Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Cinctive Capital Management LP Reduces Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Short Interest Down 18.1% in February - MarketBeat
Volatility Watch: Will Elanco Animal Health Incorporated stock recover after earnings2026 Levels & Growth Focused Stock Reports - baoquankhu1.vn
Private Management Group Inc. Cuts Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Bought by Perbak Capital Partners LLP - MarketBeat
Integral Health Asset Management LLC Grows Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Dodge & Cox Sells 135,395 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Van ECK Associates Corp Cuts Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Landscape Capital Management L.L.C. Purchases 155,048 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Global Animal Parasiticides Market Size, Growth, Trends & Forecast to 2033 Merck, Virbac, Zoetis*, Elanco - openPR.com
Elanco Animal Health Incorporated $ELAN Shares Bought by Capital World Investors - MarketBeat
Elanco Animal Health Incorporated $ELAN Position Lessened by First Trust Advisors LP - MarketBeat
Elanco Stock Analysis: Strong Gains Mask Revenue, Margin Concerns | 2026News and Statistics - IndexBox
Barrow Hanley Mewhinney & Strauss LLC Sells 2,592,747 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
UBS maintains Buy on ELAN (Elanco Animal Health Incorporated) March 2026 - Meyka
Elanco (ELAN) executive receives grant of 1,360 deferred stock units - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons receives 4,497 deferred stock units grant - Stock Titan
Elanco (NYSE: ELAN) CFO receives deferred stock unit award - Stock Titan
Elanco (NYSE: ELAN) officer receives new deferred stock unit grant - Stock Titan
Elanco Animal Health stock reaffirmed at Buy by UBS on innovation momentum - Investing.com Canada
Livestock Pharmaceutical Sales Still Booming Despite Public Health Concerns - sentientmedia.org
Citigroup Inc. Cuts Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN) - The Globe and Mail
A Look At Elanco Animal Health’s Valuation After A Year Of Strong Returns And Recent Share Price Pullback - Yahoo Finance
How Elanco Animal Health Incorporated stock performs in high volatility marketsJuly 2025 Price Swings & Real-Time Market Sentiment Alerts - Naître et grandir
Teachers Retirement System of The State of Kentucky Purchases Shares of 110,000 Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (NYSE: ELAN) officer uses 4,392 shares for tax withholding - Stock Titan
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.18%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):